HU
HUM.F Humana Inc
- Market cap
- EUR 47.3B
- P/E
- 44.7x
- P/B
- 2.85x
- ROE
- 14.5%
- Dividend yield
- 0.79%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is HUM.F undervalued?
Graham numberHUM.F trades 137.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Humana Inc fundamental analysis
No fundamental analysis for Humana Inc yet.
Humana Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Humana Inc
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and …
Full company profileHumana Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Humana Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 54.4B | 53.8B | 56.9B | 64.9B | 77.2B | 83.1B | 92.9B | 106B | 118B | 130B | 162B |
| Gross Profit | 9.37B | 10.3B | 11.0B | 11.0B | - | - | - | - | - | - | - |
| Operating Income | 1.85B | 3.47B | 3.11B | 3.24B | - | - | - | - | - | - | - |
| Net Income | 614M | 2.45B | 1.68B | 2.71B | 3.37B | 2.93B | 2.81B | 2.49B | 1.21B | 1.19B | 2.72B |
| EPS | - | 18 | 12 | 20 | 26 | 23 | 22 | 20 | 10 | 9.85 | 23 |
| Balance Sheet | |||||||||||
| Total Assets | 25.4B | 27.2B | 25.4B | 29.1B | 35.0B | 44.3B | 43.1B | 47.1B | 46.5B | 48.9B | 57.3B |
| Total Liabilities | 14.7B | 17.3B | 15.3B | 17.0B | 21.2B | 28.2B | 27.7B | 30.7B | 30.0B | 31.2B | 38.4B |
| Shareholders' Equity | 10.7B | 9.84B | 10.2B | 12.0B | 13.7B | 16.1B | 15.3B | 16.3B | 16.4B | 17.7B | 18.8B |
| Cash & Short-term Investments | 3.88B | 4.04B | 2.34B | 4.05B | 4.67B | 3.39B | 5.06B | 4.69B | 2.22B | 4.20B | 6.94B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.94B | 4.05B | 2.17B | 5.28B | 5.64B | 2.26B | 4.59B | 5.99B | 2.97B | 921M | 7.18B |
| Capital Expenditure | 527M | 524M | 612M | 736M | 964M | 1.32B | 1.12B | 979M | 575M | 546M | 520M |
| Free Cash Flow | - | 3.53B | 1.56B | 4.55B | 4.68B | 946M | 3.47B | 5.01B | 2.39B | 375M | 6.66B |
| Ratios | |||||||||||
| ROE | 5.7% | 24.9% | 16.6% | 22.5% | 24.5% | 18.2% | 18.3% | 15.3% | 7.4% | 6.7% | 14.5% |
| ROA | 2.4% | 9.0% | 6.6% | 9.3% | 9.6% | 6.6% | 6.5% | 5.3% | 2.6% | 2.4% | 4.8% |
| Net Profit Margin | 1.1% | 4.6% | 3.0% | 4.2% | 4.4% | 3.5% | 3.0% | 2.3% | 1.0% | 0.9% | 1.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Humana Inc dividends
- Dividend yield
- 0.79%
- Forward dividend
- 3.17 EUR
- Payout ratio
- 36.2%
- Ex-dividend date
- Dec 28, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 430M | 3.57 | 36.2% |
| 2024 | USD 431M | 3.57 | 35.7% |
| 2023 | USD 421M | 3.44 | 16.9% |
| 2022 | USD 392M | 3.14 | 14.0% |
| 2021 | USD 354M | 2.75 | 12.1% |
| 2020 | USD 323M | 2.51 | 9.6% |
| 2019 | USD 291M | 2.20 | 10.7% |
| 2018 | USD 265M | 1.95 | 15.7% |
| 2017 | USD 220M | 1.60 | 9.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Humana Inc
- Insiders 0.21%
- Institutions 99.79%
- Public & others 0.00%
- Shares outstanding 120M
- Free float 120M
Humana Inc company profile
- Company name
- Humana Inc
- Ticker
- HUM.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 67,060
- Fiscal year end
- December
- Address
- Humana Building, Louisville, KY, United States, 40202
- Phone
- 502 580 1000
- Website
- humana.com
About Humana Inc
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Humana Inc management
10- Mr. James A. Rechtin M.B.A.President, CEO & Director · born 1971
- Ms. Celeste Marie MelletChief Financial Officer · born 1977
- Mr. Japan A. MehtaChief Information Officer · born 1981
- Ms. Michelle A. O'HaraChief Human Resources Officer · born 1976
- Dr. Sanjay K. Shetty M.B.A., M.D.President of CenterWell · born 1974
- Mr. John-Paul William FelterSenior VP, Chief Accounting Officer & Controller · born 1983
- Mr. Bobby MukundanSenior VP & CTO
- Ms. Lisa M. StonerVice President of Investor Relations
- Mr. Joseph C. VenturaChief Legal Officer · born 1977
- Mr. Bruce Dale BroussardStrategic Advisor · born 1962